Tigatuzumab
CAS: 918127-53-4
Ref. TM-T76793
| 1mg | 238.00 € | ||
| 5mg | 602.00 € | ||
| 10mg | 1,015.00 € | ||
| 25mg | 1,502.00 € | ||
| 50mg | 1,959.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
Tigatuzumab
Synonyms:
- TRA-8
- TRA8
- CS-1008
- CS1008
- Anti-Human TRAIL-R2 Recombinant Antibody
Description:
Tigatuzumab (CS-1008) is a humanized monoclonal antibody targeting DR5 and is a TRAIL-R2 agonist with antitumor activity that induces apoptosis in cancer cells.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
144.6 (kDa)
Purity:
95% - 95%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76793 Tigatuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
